Complete Genomics

Complete Genomics Partners with Integrated DNA Technologies to Establish New Ecosystem of NGS Products

Retrieved on: 
Mercoledì, Ottobre 18, 2023
Linda, Complete Genomics, Laboratory, Genomics, IDT, Infection, RNA interference, RNA, CRISPR, PCR, Research, Learning, MGI, NGS, Commercial, Ecosystem, Partnership, Workflow, Integrated DNA Technologies, Synthetic biology, Integration, Marketing, SAN, Completeness, Antibiotics

SAN JOSE, California, Oct. 18, 2023 /PRNewswire/ -- Complete Genomics, Inc., a pioneering genomic sequencing company, today announced its partnership with Integrated DNA Technologies (IDT), a global genomics solutions provider, to develop an ecosystem of advanced compatible products based on Complete Genomics' innovative DNBSEQ™ sequencing platforms.

Key Points: 
  • SAN JOSE, California, Oct. 18, 2023 /PRNewswire/ -- Complete Genomics, Inc., a pioneering genomic sequencing company, today announced its partnership with Integrated DNA Technologies (IDT), a global genomics solutions provider, to develop an ecosystem of advanced compatible products based on Complete Genomics' innovative DNBSEQ™ sequencing platforms.
  • Its relationship with MGI, parent company of Complete Genomics, started in June 2018.
  • With Complete Genomics' technical support, IDT has empowered users in library preparation through conversion workflow and data generated by targeted sequencing.
  • With an increasing installation base of DNBSEQ sequencing platforms, the companies are enhancing their partnership by optimizing IDT's technology for Complete Genomics' sequencing platforms.

Complete Genomics Garners the Prestigious 2023 R&D 100 Awards for Cutting-Edge Innovation

Retrieved on: 
Mercoledì, Agosto 23, 2023
DTC, DNA, Completeness, Genomics, NGS, Complete Genomics, Innovation, Research, IP, Government, Science, Whole genome sequencing, Silicon, T20, SAN, Entrepreneurship, R, Health, Genome, Antibiotics

This distinguished accolade stands as a testament to Complete Genomics innovative sequencing technologies and enduring impact on the industry.

Key Points: 
  • This distinguished accolade stands as a testament to Complete Genomics innovative sequencing technologies and enduring impact on the industry.
  • With this innovation, Complete Genomics further enhances sequencing capabilities and enables researchers to accelerates scientific breakthroughs by doubling the efficiency of DNA sequencing.
  • Founded in 2005 in Silicon Valley, Complete Genomics offers complete end-to-end NGS solutions, including sample extraction, library prep, automation system, sequencing platforms, and bioinformatics.
  • Complete Genomics will formally accept the award at a gala banquet on Nov. 16, 2023 in San Diego.

Complete Genomics Announces Updated Mission and New Partnerships on 18th Anniversary

Retrieved on: 
Mercoledì, Giugno 14, 2023
DNA, Partnership, Completeness, Education, Health, John J. Carty Award for the Advancement of Science, CSO, Genomics, Genetic distance, Biotechnology, NGS, Complete Genomics, Research, Vanderbilt University, MRD, Student, RUO, SAN, Blood, WGS, Growth, Entrepreneurship, Ecosystem, Genome, Antibiotics

SAN JOSE, Calif., June 14, 2023 /PRNewswire/ -- Complete Genomics, Inc., a pioneering genomics company, today unveiled updated mission/vision statement to reflect renewed ambitions in taking on more for a better world, in celebration of its 18th anniversary.

Key Points: 
  • SAN JOSE, Calif., June 14, 2023 /PRNewswire/ -- Complete Genomics, Inc., a pioneering genomics company, today unveiled updated mission/vision statement to reflect renewed ambitions in taking on more for a better world, in celebration of its 18th anniversary.
  • Aligned with this new mission, Complete Genomics announced multiple donations for advancing genomics education and cancer care, as well as key partnerships with several biotechnology companies.
  • It also celebrates the company's progress and impact on the field of genomics and healthcare over the last 18 years.
  • "As we continue to grow in the great state of California, Complete Genomics has come a long way.

Invivoscribe Partners with Complete Genomics to Develop and Commercialize Biomarker Tests for Oncology and Cancer Research

Retrieved on: 
Venerdì, Giugno 2, 2023
Survival rate, Partnership, IVDR, CSO, Genomics, NGS, Survival, Bone marrow, Complete Genomics, Research, Acute myeloid leukemia, MRD, AML, RUO, Patient, Laboratory, Blood, SAN, FLT3, IVD, Growth, FDA, Minimal residual disease, PCR, Medical device, Vaccine

SAN DIEGO and SAN JOSE, Calif., June 2, 2023 /PRNewswire/ -- Invivoscribe and Complete Genomics announced today that they had entered a partnership to develop and commercialize biomarker tests on Complete Genomics' NGS platforms.

Key Points: 
  • SAN DIEGO and SAN JOSE, Calif., June 2, 2023 /PRNewswire/ -- Invivoscribe and Complete Genomics announced today that they had entered a partnership to develop and commercialize biomarker tests on Complete Genomics' NGS platforms.
  • The territory is worldwide, and the field is oncology and cancer research.
  • Under the terms of the deal, Invivoscribe will be responsible for the development of biomarker tests, including test controls and associated bioinformatics software.
  • "We are thrilled to be partnering with Invivoscribe, a proven developer of high-quality tests to deliver a complete workflow solution," Yongwei Zhang, CEO of Complete Genomics.

Invivoscribe Partners with Complete Genomics to Develop and Commercialize Biomarker Tests for Oncology and Cancer Research

Retrieved on: 
Venerdì, Giugno 2, 2023
Survival rate, Partnership, IVDR, CSO, Genomics, NGS, Survival, Bone marrow, Complete Genomics, Research, Acute myeloid leukemia, MRD, AML, RUO, Patient, Laboratory, Blood, SAN, FLT3, IVD, Growth, FDA, Minimal residual disease, PCR, Medical device, Vaccine

SAN DIEGO and SAN JOSE, Calif., June 2, 2023 /PRNewswire/ -- Invivoscribe and Complete Genomics announced today that they had entered a partnership to develop and commercialize biomarker tests on Complete Genomics' NGS platforms.

Key Points: 
  • SAN DIEGO and SAN JOSE, Calif., June 2, 2023 /PRNewswire/ -- Invivoscribe and Complete Genomics announced today that they had entered a partnership to develop and commercialize biomarker tests on Complete Genomics' NGS platforms.
  • The territory is worldwide, and the field is oncology and cancer research.
  • Under the terms of the deal, Invivoscribe will be responsible for the development of biomarker tests, including test controls and associated bioinformatics software.
  • "We are thrilled to be partnering with Invivoscribe, a proven developer of high-quality tests to deliver a complete workflow solution," Yongwei Zhang, CEO of Complete Genomics.

Dante Genomics offers free, first-step feature of its AVANTI Software to turn FASTQ to VCF files on its platform agnostic genomic interpretation software

Retrieved on: 
Lunedì, Maggio 15, 2023
DNA, VCF, Microsoft Windows, Genomics, FASTQ, NGS, Complete Genomics, Microsoft, Software, Ultima, Patient, AVANTI, Medicine, Element, Neurology, MGI, Antibiotics, Medical imaging, Illumina

NEW YORK, May 15, 2023 /PRNewswire/ -- Dante Genomics, a global leader in genomics and precision medicine, today announced a free, initial feature of its platform agnostic proprietary B2B software to automatically turn FASTQ files to VCF files at no charge as an introduction to its AVANTI Software, demonstrating the broad scalability of its interpretation software to benefit sequencing labs of all sizes around the world.

Key Points: 
  • The transformation to VCF is difficult and complicated and would normally require an expert IT team to accomplish.
  • In offering the transformation for free, Dante is demonstrating the utility of this plug-and-play approach to genomic interpretation at scale.
  • The AVANTI Software is platform agnostic and compatible with all sequencers, including Illumina, Pac Bio, Oxford Nanopore, Complete Genomics, Ultima, Element and MGI, among others.
  • To learn more about Dante's AVANTI Software and to sign up and start generating reports in minutes, visit https://avanti.dantegenomics.com .

Dante Genomics offers free, first-step feature of its AVANTI Software to turn FASTQ to VCF files on its platform agnostic genomic interpretation software

Retrieved on: 
Lunedì, Maggio 15, 2023
DNA, VCF, Microsoft Windows, Genomics, FASTQ, NGS, Complete Genomics, Microsoft, Software, Ultima, Patient, AVANTI, Medicine, Element, Neurology, MGI, Antibiotics, Medical imaging, Illumina

NEW YORK, May 15, 2023 /PRNewswire/ -- Dante Genomics, a global leader in genomics and precision medicine, today announced a free, initial feature of its platform agnostic proprietary B2B software to automatically turn FASTQ files to VCF files at no charge as an introduction to its AVANTI Software, demonstrating the broad scalability of its interpretation software to benefit sequencing labs of all sizes around the world.

Key Points: 
  • The transformation to VCF is difficult and complicated and would normally require an expert IT team to accomplish.
  • In offering the transformation for free, Dante is demonstrating the utility of this plug-and-play approach to genomic interpretation at scale.
  • The AVANTI Software is platform agnostic and compatible with all sequencers, including Illumina, Pac Bio, Oxford Nanopore, Complete Genomics, Ultima, Element and MGI, among others.
  • To learn more about Dante's AVANTI Software and to sign up and start generating reports in minutes, visit https://avanti.dantegenomics.com .

Integrated DNA Technologies Debuts Collab Network

Retrieved on: 
Martedì, Febbraio 7, 2023
Health, Genetics, Other Science, Research, Science, Biotechnology, Singular, Synthetic biology, Integration, Complete Genomics, Integrated DNA Technologies, Genomics, IDT, Medicine, PCR, PerkinElmer, CRISPR, Robotics, RNA, Helix, Infection, Multimedia, Learning, RNA interference, Vaccine

With a mission to accelerate the pace of genomics, Integrated DNA Technologies (IDT) has launched Collab Network, a first-of-its-kind IDT program aimed at uniting researchers and industry partners under a single, impactful research network to foster learning, collaboration and future technology development.

Key Points: 
  • With a mission to accelerate the pace of genomics, Integrated DNA Technologies (IDT) has launched Collab Network, a first-of-its-kind IDT program aimed at uniting researchers and industry partners under a single, impactful research network to foster learning, collaboration and future technology development.
  • The Collab Network Program was officially unveiled at the 2023 Advances in Genome Biology and Technology General Meeting taking place Feb. 6 to Feb. 9 in Hollywood, Fla.
  • View the full release here: https://www.businesswire.com/news/home/20230207005228/en/
    The IDT Collab Network provides members access to new opportunities to advance their research through the support of IDT’s global network.
  • For additional information on the Collab Network, view a full list of members, or to submit a request to join the group, visit https://www.idtdna.com/pages/about/collabs-network/collaborators .

Complete Genomics Drops Genome Sequencing Price to Sub $100 at AGBT General Meeting

Retrieved on: 
Martedì, Febbraio 7, 2023
DNA, Biomarker, Medicine, Library, BBS, Complete Genomics, Genomics, Real-time, Patient, WGBS, CT, WGS, Monkeypox virus, Research, Rover G series, RNA-Seq, Immersion, Mass meeting, WES, John J. Carty Award for the Advancement of Science, MGI, Deterministic Barcoding in Tissue for Spatial Omics Sequencing, Depreciation, Silicon, Genome, Doctor of Philosophy, Fine chemical, Vaccine, Injection moulding, Computer data storage, Antibiotics, Mpox

HOLLYWOOD, Fla., Feb. 7, 2023 /PRNewswire/ -- Complete Genomics Inc., a global life science tools leader and subsidiary of MGI Tech Co., Ltd. ("MGI"), today launched new revolutionary products and prices at Advances in Genome Biology and Technology (AGBT) General Meeting.

Key Points: 
  • Complete Genomics offers T Series, G Series, and E Series genetic sequencers covering wide range from low- medium- high- ultra high throughput sequencing applications.
  • During the conference, Complete Genomics also announced a stunning new US reagent promotional price of $1.5/Gb for its flagship sequencer DNBSEQ-T7 that is already on the market.
  • Complete Genomics, an innovative sequencing systems company, is now offering six sequencers to US sequencing labs including portable sequencer DNBSEQ-E25*, and high throughput sequencer DNBSEQ-T10×4, and medium throughput benchtop sequencer DNBSEQ-G400*.
  • Complete Genomics also provides sample and library prep automation and downstream bioinformatics solutions.

Complete Genomics to Announce New Product Launches at AGBT General Meeting

Retrieved on: 
Martedì, Gennaio 24, 2023
Complete Genomics, Mass meeting, MGI, Genomics, SAN, Investment, Doctor of Philosophy, Science, Antibiotics

"We are excited to unveil our new massively parallel next-generation sequencing products at this year's AGBT meeting.

Key Points: 
  • "We are excited to unveil our new massively parallel next-generation sequencing products at this year's AGBT meeting.
  • Complete Genomics is advancing life science technology with an innovative product portfolio based on its highly efficient and accurate core technology known as DNBSEQ™.
  • Complete Genomics offers quality genetic sequencers covering a wide range of applications from low,tomedium, and to ultra-high sequencing throughput.
  • Please plan to join us in the Complete Genomics Suite #318 to learn more about our DNBSEQ™ sequencing and laboratory automation platforms and see product demonstrations.